Psychiatry and Neurology, Neurology · Kirkland, WA
NPI
1245223296
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
12039 NE 128th St, Suite 300
Kirkland, WA, 98034
Phone (425) 899-3123
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
920 services
Medicare patients, 2024
188
Average age 76
Drug cost, 2024
$1.6M
3,401 prescriptions
Company payments, 2025
$184K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pinky Agarwal was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 353 times for 163 patients. In total Pinky Agarwal billed 920 services in 17 codes, and Medicare paid $47K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 353 | 163 | $12.35 | $4,359 |
| 99214 Office E&M - Established | Facility | 338 | 156 | $70.33 | $24K |
| 99205 Office E&M - New | Facility | 40 | 40 | $144.28 | $5,771 |
| 99215 Office E&M - Established | Facility | 40 | 30 | $108.09 | $4,324 |
| 95970 Electrical Nerve Conductivity | Facility | 33 | 17 | $14.39 | $475 |
| 64611 Musculoskeletal | Facility | 30 | 13 | $90.98 | $2,729 |
| 95874 Musculoskeletal | Facility | 27 | 11 | $15.16 | $409 |
By year: 2022 $47K for 586 services; 2023 $45K for 569 services; 2024 $47K for 920 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pinky Agarwal prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 880 prescriptions and refills. In total Pinky Agarwal wrote 3,401 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 880 | 2,062 | 225 | $36K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 342 | 778 | 90 | $27K |
| Rytary Carbidopa/Levodopa | 228 | 416 | 49 | $412K |
| Donepezil Hcl Generic | 176 | 395 | 46 | $2,041 |
| Quetiapine Fumarate Generic | 135 | 255 | 33 | $2,154 |
| Nourianz Istradefylline | 108 | 128 | 18 | $243K |
| Rasagiline Mesylate Generic | 98 | 233 | 31 | $18K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 96 | 242 | 27 | $2,147 |
| Fludrocortisone Acetate Generic | 85 | 175 | 26 | $2,498 |
| Clonazepam Generic | 83 | 170 | 21 | $1,114 |
| Rivastigmine Rivastigmine Tartrate | 83 | 133 | 19 | $7,229 |
| Escitalopram Oxalate Generic | 74 | 178 | 20 | $667 |
| Gabapentin Generic | 70 | 174 | 26 | $1,145 |
| Nuplazid Pimavanserin Tartrate | 67 | 69 | 11 | $347K |
| Amantadine Amantadine Hcl | 67 | 181 | 23 | $4,831 |
Brand drugs: 596 claims; generic drugs: 2,805 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pinky Agarwal $184K ($184K in general payments such as food, travel and fees) from 28 companies. The largest payer was MDD US Operations, LLC with $99K.
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 140 | $99K |
| Neurocrine BioSciences, Inc. NBIX | 29 | $22K |
| Merz Pharmaceuticals, LLC | 24 | $21K |
| Abbvie Inc. ABBV | 26 | $18K |
| ACADIA Pharmaceuticals Inc ACAD | 23 | $12K |
| Eli Lilly and Company LLY | 4 | $6,134 |
| Tanabe Pharma America, Inc. | 1 | $3,300 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $1,688 |
| Janssen Biotech, Inc. JNJ | 5 | $143 |
| Eisai Inc. 4523.T | 1 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.